The PANTHER overrepresentation test [44, 45] revealed that the Notch signaling and PI3 kinase pathways (Fig. 6E, F), which are known to be involved in BRAF or MEK inhibitor resistance in melanoma [46–51], were exclusively identified in the list of hits obtained by analyzing v. The gene discussed is BRAF; the disease is melanoma.